Please login to the form below

Not currently logged in
Email:
Password:

The Grey Healthcare Group Award for Excellence in Health Improvement and Education

Sponsored by

Finalist

Think Test for HIV

Bristol-Myers Squibb in association with Mash Health


Summary of work

Late diagnosis of HIV remains an issue in the UK, affecting morbidity and mortality. While guidelines set out criteria for testing outside the genitourinary medicine (GUM) setting, testing in other specialties remains low. 

We worked with Bristol-Myers Squibb to develop a programme designed to increase HIV testing in non-GUM Secondary Care settings. In the 10 months since launch, the ‘Think Test for HIV’ initiative has been adopted in more than 38 hospitals. In one hospital, this has already resulted in a 60 per cent increase in HIV testing and a 13 per cent increase in early diagnosis – directly impacting on patients’ lives.

 

 

Executive summary as submitted


COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Videum Health

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...

Latest intelligence

Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...
Pharma M&A
Pharma funding and M&A in 2020
Why pharma M&A has continually bucked the trend...
Behaviour change through medical education: How can we turn aspiration into reality?
Practical, evidence-based insights into a CME process that aims to effect measurable behaviour change...

Infographics